輸入代號或公司名稱後按 Enter
6461

益得

+1.25 (+5.14%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
25.55105成交張數本益比3.15股價淨值比0.00%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q2-0.59-2.92-1.03-545.4%-10.89%-47.57%
2026Q1-0.63-2.57-1.12-635.0%-10.69%-47.98%
2025Q4-0.77-2.57-1.23-2557.6%-11.81%-40.62%
2025Q3-0.93-2.54-1.44-1979.1%-13.59%-39.05%
2025Q2-0.24-2.30-0.33-37.9%-3.57%-30.16%
2025Q1-0.63-2.71-0.88-1154.0%-11.46%-41.87%
2024Q4-0.74-2.63-1.05-939.0%-12.15%-37.15%
2024Q3-0.69-2.63-0.96-1109.1%-10.03%-42.40%
2024Q2-0.66-2.70-0.93-1778.8%-8.82%-37.26%
2024Q1-0.54-2.63-0.75-507.2%-6.62%-32.39%
2023Q4-0.74-2.75-0.98-1804.1%-9.99%-30.73%
2023Q3-0.76-2.82-0.86-1251.4%-10.22%-35.31%
2023Q2-0.59-2.68-0.73-735.3%-7.93%-31.70%
2023Q1-0.66-2.77-0.81-2225.9%-8.18%-30.56%
2022Q4-0.81-2.68-0.99-2351.6%-9.21%-27.68%
2022Q3-0.62-2.59-0.75-2920.5%-6.50%-27.65%
2022Q2-0.68-2.66-0.84-1484.5%-6.87%-25.77%
2022Q1-0.57-2.75-0.69-619.5%-5.31%-23.93%
2021Q4-0.72-2.82-0.80-590.5%-6.53%-22.63%
2021Q3-0.68-2.71-0.72-510.5%-6.26%-23.01%
2021Q2-0.77-2.65-0.82-1973.0%-6.74%-21.38%
2021Q1-0.64-2.43-0.68-948.7%-5.24%-18.66%
2020Q4-0.61-2.36-0.65-1128.8%-4.80%-17.28%
2020Q3-0.62-2.68-0.66-1840.4%-4.63%-20.33%
2020Q2-0.56-3.04-0.60-924.4%-4.04%-20.44%
2020Q1-0.57-3.37-0.60-1128.1%-3.90%-20.68%
2019Q4-0.93-3.60-0.85-2183.0%-5.97%-20.37%
2019Q3-0.98-3.29-0.81-1802.3%-6.20%-19.96%
2019Q2-0.89-2.94-0.77-1915.5%-5.58%-17.37%
2019Q1-0.80-0.69-1602.1%-4.73%
2018Q4-0.62-0.54-1069.7%-3.54%
2018Q3-0.64-0.56-1385.9%-3.56%
2018Q2-0.72-0.62-1554.4%